Cours disponibles

For teachers only

This section should help you to understand :

  • What is DCR Moodle platform?
  • How to create and manage a course space?
  • How to add/manage resources?
  • How to add/manage activities?
  • How to enroll/unroll students?
  • How to form student groups and group activities?
  • How to create an exam?
  • How to create an attendance list?
  • How to provide a course certificate?
For teachers only

This section is dedicated to exploration, experimentation, and creativity! 🎨

Add, delete, and change elements freely and let yourself be surprised by the possibilities (and limitations) of Moodle!

Just keep in mind that anyone can access and modify this section, so let's remain professional and respectful!

Learning objectives

  • Describe the various costs associated with all aspects of clinical trials for both the research and general community
  • Analyze the factors that influence a study budget, including how different trial designs impact cost components.
  • Evaluate the challenges involved in accurately estimating a study budget and identify strategies to address them
  • Identify and differentiate the various types of costs encountered in clinical trial budget estimation

Module Summary

CONTENT

Module Summary

At the core of the clinical trials process lays the investigational medicinal product (IMP). Successful studies rely on the quality and efficient, timely delivery of their clinical trial supplies. The EU Directive on Clinical Trials (2001/20/EC) requires that all commercial clinical trials must be conducted using Good Manufacturing Practice (GMP) compliant supplies. IMP should be manufactured, handled and stored in accordance with applicable GMP. In practice, the IML lifecycle involves 7 sequential steps: study and packaging design, label design and randomization, packaging, distribution, study conduct, returns and drug accounting and destruction.

Clinical trials on medicinal products are regulated under the Human Research Act (HRA), especially via the Clinical Trials Ordinance (ClinO). Swissmedic is the competent authority for medicinal products; swissethics is the body for ethics committee oversight. From 15 August 2025, Switzerland apply ICH GCP E6(R3) Principles and Annex 1. 

Module Summary

The basic Statistics course prepares learners to apply core statistical concepts in the context of clinical research. Participants will learn to apply key statistical principles, distinguish between common study designs and justify their selection based on specific research objectives, and construct research questions that are aligned to statistical principles. They will develop the ability to outline and critically review the key components of the statistic aspects of a study protocol and a statistical analysis plan. In addition, learners will assess when advanced trial designs—such as adaptive trials—are warranted and appraise their implications for study implementation and interpretation.

Module Summary

CONTENT

Module Summary

Please find in this module all the documents and supporting materials required to successfully complete your immersion week at the Department of Clinical Research (DCR) Bern.

If you have any questions, please contact education.dcr@unibe.ch

All the information you need to prepare your DCR PPI consultation 1.

Key point summary of your first DCR PPI consultation.

An overview of the support the DCR PPI team can provide.

.text-white

Information and templates to help you prepare and submit the PPI sections of your Letter of Intent (LOI).

Lernergebnisse

Am Ende dieses Kurses sind die Teilnehmer in der Lage, klinische Forschung am Menschen, klinische Studien und Beobachtungsstudien zu definieren sowie die Elemente des klinischen Studienprozesses und die Phasen klinischer Studien zu beschreiben.

Lernergebnisse

Am Ende dieses Kurses werden die Teilnehmer in der Lage sein:

  • den Zweck des Schweizer Gesetzes über die Forschung am Menschen, der Deklaration von Helsinki und der Grundsätze der guten klinischen Praxis definieren und erläutern
  • den Prozess der Prüfung und Genehmigung klinischer Studien beschreiben
  • die verschiedenen Rollen in klinischen Studien sowie die mit jeder Rolle verbundenen ethischen Verantwortlichkeiten, wissenschaftlichen Vorschriften und rechtlichen Anforderungen definieren

Lernergebnisse

Am Ende dieses Kurses werden die Teilnehmer in der Lage sein:

  • Beschreiben Sie die vier Phasen klinischer Studien – einschließlich der Entwicklungs-, Planungs-, Durchführungs- und Abschlussphase – und was jede Phase beinhaltet
  • die Abschnitte des Studienprotokolls und die Rolle der wesentlichen Dokumente in klinischen Studien erläutern
  • beschreibt die Durchführungsphase, einschließlich der Anwendung von Ein- und Ausschlusskriterien bei der Vorauswahl und Rekrutierung potenzieller Teilnehmer sowie den Ablauf der Studienbesuche
  • einen Überblick darüber zu geben, wie klinische Studien abgeschlossen werden und wie Informationen an die wissenschaftliche Gemeinschaft und die Öffentlichkeit weitergegeben werden

Lernergebnisse

Am Ende dieses Kurses werden die Teilnehmer in der Lage sein:

  • Definieren Sie den Begriff „Patient and Public Involvement“ (PPI) im Zusammenhang mit der klinischen Forschung
  • beschreiben, welche Rolle PPI-Contributor in der klinischen Forschung spielen, welche Rechte und Pflichten sie haben und wie sie sich auf ihre Arbeit vorbereiten können

Learning outcomes

At the end of this course participants will be able to define clinical research with humans, clinical trials, and observational studies and to describes elements of the clinical trial process and clinical trial phases.

Learning outcomes

At the end of this course participants will be able to:

  • defines and explains the purpose of the Swiss Human Research Act, the Declaration of Helsinki, and the Rules of Good Clinical Practice
  • describes the process of reviewing and approving clinical trials
  • defines the various roles in clinical studies and the ethical responsibilities, scientific regulations, and legal requirements associated with each role

Learning outcomes

At the end of this course participants will be able to:

  • describes the four stages of clinical trials—including the development, planning, implementation, and concluding stages—and what each stage entails
  • explains the study protocol sections and the role of essential documents in clinical trials
  • details the implementation stage, including applying inclusion and exclusion criteria when screening and recruiting potential participants, and what happens during study visits
  • overviews how clinical trials are concluded and how information is shared with the scientific community and the public

Learning outcomes

By the end of this course, participants will be able to:

  • Define the term “Patient and Public Involvement” (PPI) in the context of clinical research
  • Describe the role of PPI contributors in clinical research, their rights and responsibilities, and how they can prepare for their work

Acquis d'apprentissage

A la fin de ce cours, les participants seront capables de définir la recherche clinique chez l'humain, les essais cliniques, et les études observationnelles, de décrire les processus et les phases des essais cliniques.

Acquis d'apprentissage

A la fin de ce cours, les participants seront capables de:

  • définir et expliquer l'objectif de la loi suisse relative à la recherche sur l'être humain, de la Déclaration d'Helsinki et des règles de bonnes pratiques cliniques
  • décrire le processus d'examen et d'approbation des essais cliniques
  • définir les différents rôles dans les essais cliniques, ainsi que les responsabilités éthiques, les réglementations scientifiques et les exigences légales associées à chacun de ces rôles

Acquis d'apprentissage

A la fin de ce cours, les participants seront capables de:

  • décrire les quatre phases des essais cliniques — à savoir la conception, la planification, la mise en œuvre et la conclusion — ainsi que ce que chacune d'elles implique
  • expliquer les différentes sections du protocole d'étude et le rôle des documents essentiels dans les essais cliniques
  • décrire en détail la phase de mise en œuvre, notamment l'application des critères d'inclusion et d'exclusion lors de la sélection et du recrutement des participants potentiels, ainsi que le déroulement des visites de suivi
  • avoir une vue d'ensemble de la manière dont les essais cliniques sont menés à bien et dont les informations sont communiquées à la communauté scientifique et au grand public

Acquis d'apprentissage

A la fin de ce cours, les participants seront capable de:

  • Définir la notion de « Patients and Public Involvement » (PPI) dans le contexte de la recherche clinique
  • Décrire le rôle des contributeurs PPI dans la recherche clinique, leurs droits et leurs obligations, ainsi que la manière dont ils peuvent se préparer à leur travail

Learning objectives

  • Describe the various costs associated with all aspects of clinical trials for both the research and general community
  • Analyze the factors that influence a study budget, including how different trial designs impact cost components.
  • Evaluate the challenges involved in accurately estimating a study budget and identify strategies to address them
  • Identify and differentiate the various types of costs encountered in clinical trial budget estimation

Module Summary

The basic Statistics course prepares learners to apply core statistical concepts in the context of clinical research. Participants will learn to apply key statistical principles, distinguish between common study designs and justify their selection based on specific research objectives, and construct research questions that are aligned to statistical principles. They will develop the ability to outline and critically review the key components of the statistic aspects of a study protocol and a statistical analysis plan. In addition, learners will assess when advanced trial designs—such as adaptive trials—are warranted and appraise their implications for study implementation and interpretation.